Summary Judgment of Earn-out Litigation for Change Healthcare

We obtained summary judgment on behalf of Change Healthcare and related entities in federal court litigation in Seattle stemming from Change Healthcare’s acquisition of a start-up business in the healthcare technology industry where the stock purchase agreement had contingent earn-out provisions. The former shareholders of the start-up business alleged, among other claims, breach of the implied covenant of good faith and fair dealing and breach of contract under Delaware law. Representative matters include: Lilly v. Envoy, LLC, No. C15-0742RSM, 2016 WL 7375271 (W.D. Wash. Dec. 20, 2016). 

Change Healthcare (formerly NYSE: EM) is a leading provider of software and analytics, network solutions and technology-enabled services that optimize communications, payments and actionable insights designed to enable smarter healthcare.

You Also May Be Interested In:

  • We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company
  • Bass, Berry & Sims served as lead counsel to Tennessee Orthopedic Alliance (TOA) in obtaining a Certificate of Need (CON)...
    Client Type: Private Company
  • Lead counsel representing emergency department provider and other defendants in qui tam lawsuit alleging violation of licensure laws caused submission of false claims. District court dismissed allegations against the emergency department provider on grounds that alleged regulatory violation did not satisfy standard for FCA materiality set forth in Supreme Court’s Escobar decision. U.S. ex rel. Taylor v. Boyko, 2019 WL 2423283 (S.D. W. Va. Jun. 6, 2019).

    Bass, Berry & Sims served as lead counsel representing an emergency department provider and other defendants in a qui tam...